The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial
2011
Abstract
Lowering LDL cholesterol with statin regimens reduces the risk of myocardial infarction, ischemic stroke and the need for coronary revascularisation in people withouth kidney disease, burt its effects in people with moderate-to-sever kidney disease are uncertain.